SEC 13F Intelligence

Farallon Capital Management, L.L.C. / BIIB

Farallon Capital Management, L.L.C.’s Biogen Inc Position

Does Farallon Capital Management, L.L.C. own Biogen Inc (BIIB)? Not currently — the last reported position was 604.1K shares worth $172M in Q2 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$172M
Q2 2023
Shares
604.1K
% of Portfolio
+0.96%
Quarters Held
11
position exited

Position History BIIB

Reported value by quarter
Q4 ’20: $25MQ4 ’20Q1 ’21: $29MQ2 ’21: $38MQ2 ’21Q3 ’21: $48MQ4 ’21: $35MQ4 ’21Q1 ’22: $42MQ2 ’22: $57MQ2 ’22Q3 ’22: $82MQ4 ’22: $164MQ4 ’22Q1 ’23: $172MQ2 ’23: $172MQ2 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2023604.1K$172M+0.96%
Q1 2023619.8K$172M+0.85%
Q4 2022592.7K$164M+1.08%
Q3 2022305.5K$82M+0.45%
Q2 2022278.5K$57M+0.32%
Q1 2022197.8K$42M+0.18%
Q4 2021147.7K$35M+0.18%
Q3 2021170.9K$48M+0.23%
Q2 2021109.0K$38M+0.16%
Q1 2021103.0K$29M+0.16%
Q4 2020103.0K$25M+0.16%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Farallon Capital Management, L.L.C.’s full portfolio or all institutional holders of BIIB.